image: Electron microscopes and modern computer image processing allowed University of Tokyo researchers to uncover the correct structure of a protein essential in the immune system, IgM, and a much smaller protein that is bound inside, AIM. IgM is the larger, incomplete hexagon shape and AIM is the smaller broad bean shape inside the wedge-shape gap. In the right-side image, AIM is more easily recognized as the bright white, broad-bean-shaped spot. view more
Credit: Image by Hiramoto et al., originally published in <em>Science Advances</em>, CC-BY
Researchers have revealed the structure of an essential immune protein, creating future possibilities to develop more effective medicines for a range of illnesses from cancer to neurological diseases. University of Tokyo researchers made this discovery with computerized image analysis and modern electron microscope imaging.
Researchers verified the structure of natural immunoglobulin M (IgM) protein, an important part of the immune system, using mouse and human versions of the protein. IgM is now understood to be shaped like an incomplete hexagon, or a pentagon with a wedge-shaped gap.
"We'll have to revise the textbooks," said Professor Toru Miyazaki, the leader of the laboratory where the IgM structure was identified at the Graduate School of Medicine.
IgM is the first immune system protein that develops in the human fetus and remains the first responder to pathogens throughout life. The structure of IgM was first identified in 1969 as a "five-pointed, star-shaped table" and updated in 2009 to be a five-sided dome or "mushroom cap."
"The original IgM model was made by looking at a few individual molecules by hand with what today we think is a low-resolution microscope. Now we have clearer pictures and the computer can examine thousands of individual IgM molecules," said Miyazaki.
The 2018 discovery of the incomplete hexagon was actually a secondary interest for Miyazaki, originally a medical doctor who has built his research career studying a different protein called apoptosis inhibitor of macrophage (AIM).
Since identifying the correct shape of IgM, researchers now understand that inactive AIM is nestled inside the gap of the IgM incomplete hexagon. The structural connection between IgM and AIM means that drugs with the ability to regulate the release of AIM could be used to create AIM-based disease therapies.
"We can think of AIM as a fighter jet and IgM as the aircraft carrier ship. When other molecules activate the immune system, IgM releases AIM. The much smaller AIM protein goes around the body to clear away damaged cells and prevent disease," said Miyazaki.
Miyazaki identified AIM in 1999 while working at the Basel Institute for Immunology Institute in Switzerland. Its small size means AIM is easily eliminated from the body by the kidneys and excreted in urine, so staying bound within the larger IgM protects AIM from being removed before it is needed.
AIM is a common molecule in the bloodstream, but it is only active when the body develops a disease. AIM is known to be important for preventing obesity, fatty liver disease, hepatocellular carcinoma (liver cancer), multiple sclerosis (MS), fungus-induced peritonitis (inflammation of the abdominal wall membrane), and acute kidney injury.
The incomplete hexagon structure is still only a 2D understanding of IgM structure. Miyazaki and his team continue to do additional analysis and hope to report the 3D structure of IgM soon.
###
About the research: The research team includes members of the University of Tokyo and the Max Planck-The University of Tokyo Center for Integrative Inflammology.
Journal Article
E. Hiramoto, A. Tsutsumi, R. Suzuki, S. Matsuoka, S. Arai, M. Kikkawa, T. Miyazaki, The IgM pentamer is an asymmetric pentagon with an open groove that binds the AIM protein. Science Advances 4: eaau1199 (2018).
Other articles mentioned in this press release:
1. Feinstein A, Munn E.A. Conformation of the Free and Antigen-bound IgM Antibody Molecules. Nature 224(5226): 1307-1309 (1969). DOI: 10.1038/2241307a0 https://www.nature.com/articles/2241307a0.pdf
2. Czajkowsky DM and Shao Z. The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proceedings of the National Academy of Sciences of the United States of America 106(39): 14960-14965 (2009). DOI: 10.1073/pnas.0903805106 http://www.pnas.org/content/106/35/14960.full
Related Links
Center for Disease Biology and Integrative Medicine website: http://www.cdbim.m.u-tokyo.ac.jp/english/index.php
Graduate School of Medicine and Faculty of Medicine website: http://www.m.u-tokyo.ac.jp/english/index.html
Laboratory of Molecular Biomedicine for Pathogenesis homepage: http://tmlab.m.u-tokyo.ac.jp/english/index.html
Previous news from Miyazaki Lab: https://www.u-tokyo.ac.jp/focus/en/features/f_00005.html
Research Contact
Professor Toru Miyazaki
Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
Tel: +81-(0)3-5841-1436
Email: tm@m.u-tokyo.ac.jp
Press Contacts
Ms. Caitlin Devor
Division for Strategic Public Relations, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 133-8654, JAPAN
Tel: +81-3-5841-0876
Email: press-releases.adm@mail.u-tokyo.ac.jp
Public Relations Team
Faculty of Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 133-8654, JAPAN
Tel: +81-(0)3-5841-3304
E-mail: ishomu@m.u-tokyo.ac.jp
About the University of Tokyo
The University of Tokyo is Japan's leading university and one of the world's top research universities. The vast research output of some 6,000 researchers is published in the world's top journals across the arts and sciences. Our vibrant student body of around 15,000 undergraduate and 15,000 graduate students includes over 2,000 international students. Find out more at http://www.u-tokyo.ac.jp/en/ or follow us on Twitter at @UTokyo_News_en.
Journal
Science Advances